Sen. King Introduces Bipartisan Bill to Require Price Transparency in Prescription Drug Advertisements
June 30, 2021
June 30, 2021
WASHINGTON, June 30 -- Sen. Angus S. King Jr., I-Maine, issued the following news release on June 29, 2021:
Today the Office of U.S. Senator Angus King (I-Maine) announced that Senators King, Dick Durbin (D-Ill.) and Chuck Grassley (R-Iowa) have introduced the Drug-price Transparency for Competition (DTC) Act, a bill that would require price disclosures on advertisements for prescription drugs, in order to inform patients and reduce spending on medications. Specifically, the DTC Act . . .
Today the Office of U.S. Senator Angus King (I-Maine) announced that Senators King, Dick Durbin (D-Ill.) and Chuck Grassley (R-Iowa) have introduced the Drug-price Transparency for Competition (DTC) Act, a bill that would require price disclosures on advertisements for prescription drugs, in order to inform patients and reduce spending on medications. Specifically, the DTC Act . . .